Cidara Therapeutics (NASDAQ:CDTX) Shares Gap Up on Analyst

Shares of Cidara Therapeutics, Inc. (NASDAQ:CDTX – Get Free Report) gapped up prior to trading on Thursday after Needham & Company LLC raised their price target on the stock from $3.00 to $25.00. The stock had previously closed at $12.29, but opened at $14.50. Needham & Company LLC currently has a buy rating on the […]

Related Keywords

United States , , Nasdaq , Raymond James Financial Services Advisors Inc , Needham Company , Cidara Therapeutics Company Profile , Flagship Harbor Advisors , Cantor Fitzgerald , Cidara Therapeutics Inc , Cidara Therapeutics , Get Free Report , Harbor Advisors , James Financial Services Advisors , Pale Fire Capital , Cidara Therapeutics Daily , Nasdaq Cdtx , Cdtx , Medical , Stocks , Technicals ,